Premium
Mediterranean Spotted Fever in Crete, Greece
Author(s) -
GERMANAKIS A.,
PSAROULAKI A.,
GIKAS A.,
TSELENTIS Y.
Publication year - 2006
Publication title -
annals of the new york academy of sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.712
H-Index - 248
eISSN - 1749-6632
pISSN - 0077-8923
DOI - 10.1196/annals.1374.049
Subject(s) - medicine , eschar , rash , hypochloremia , doxycycline , microscopic hematuria , epidemiology , hyponatremia , serology , surgery , dermatology , pediatrics , kidney , immunology , antibody , proteinuria , biology , antibiotics , microbiology and biotechnology
The clinical, epidemiological, and therapeutic aspects of 15 patients with Mediterranean spotted fever (MSF), admitted to the Internal Medicine Department of the General Hospital of Sitia (southeastern Crete, Greece) between December 2000 and July 2003, were studied. Diagnosis was made on the basis of clinical signs and symptoms and was confirmed by serology. Of the patients studied, 67% were men and 33% women, with a median age of 52 years (range of 23–76 years). Ten cases (67%) were diagnosed between May and July. Of all the patients, 93% had a history of contact with animals, mainly with sheep (11 patients, 73%), while 53% of them had a history of tick‐bite (33%), or reported the presence of ticks in their environment (20%). The typical eschar lesion ( tache noir ) at the tick‐bite site was present in 53% of the patients, while the rash was present in 87% of them. Laboratory findings included leukopenia (47%), thrombocytopenia (54%), elevation of transaminases (80%), hyponatremia (33%), and microscopic hematuria (80%). Four patients (27%) displayed pulmonary infiltrates on chest radiography. All patients were treated with doxycycline (200 mg daily) and recovered rapidly. Renal function deteriorated in one patient with chronic renal failure, but he recovered thereafter.